Pharm Final: Diabetic Patient Flashcards
DMI vs. DMII
DMI: Insulin Dependent
- Insulin
- Adjunctive Therapies
DMII: non-insulin Dependent
- Exogenous Insulin
- Anti-diabetic Drugs
- Adjunctive Therapies
How is diabetes defined?
A hereogenous group of syndromes characterized by an elevation of blood glucose and metabolic perturbation caused by a relative or absolute insulin deficiency.
Insulin
Function:
Mechanism of Action:
Therapeutic Use:
Insulin
Function: decrease blood glucose
Mechanism of Action: stimulates peripheral glucose uptake + inhibits hepatic glucose production
Therapeutic Use: Type I and II DM, Hyperkalemia, diabetic coma
Hypoglycemia
Symptoms:
Non-Pharm Management:
PT Implications:
Hypoglycemia
BG
Thiazolindinediones
Indications:
MOA:
Thiazolindinediones
Indications: As adjunct to diet and exercise for Type II diabetes
MOA: increase insulin sensitivity by affecting PPAR-y (peroxisome proliferators-activated receptor) at adipose tissue, skeletal muscle, and in the liver
-no risk of hypoglycemia
effective in highly insulin-resistant patients
Side Effects: weight gain and edema
Meformin
Uses:
MOA:
Meformin
Uses: Preferred agent for Type 2 diabetes.
MOA: Decreases endogenous hepatic production of glucose
-Decreases plasma insulin
-No risk of hypoglycemia
Well-established history of effectiveness. Weight loss may occur. Convenient daily dosing. Many contraindications. Monitor renal function.
Adjunct Therapy in addition to Medical Managment
- Energy balance, diet, exercise: low carb, low fat, calorie restricted diet
- Cardiovascular Disease/Hypertension: reduce BP
Exercise and DM
Use:
PT Implications
-Exercise has an insulin-type effect, reducing BG
- Be aware of the signs of hypoglycemia (confusion, fatigue, sweating, nausea)
- Inquire about insulin regime, BS prior to session.
- Delay session start for snack or insulin treatment if needed.
- Have source of glucose on-hand in clinic
- Instruct patient about how exercise can alter BG
- -Adjust insulin by reducing dose 15-30%